| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | signaling receptor complex adaptor activity | 1.75e-06 | 54 | 215 | 7 | GO:0030159 | |
| GeneOntologyMolecularFunction | signaling adaptor activity | 1.10e-05 | 129 | 215 | 9 | GO:0035591 | |
| GeneOntologyMolecularFunction | benzodiazepine receptor binding | 1.21e-05 | 5 | 215 | 3 | GO:0030156 | |
| Domain | WD40 | TBL1Y CORO1C KATNB1 CDC20B WDR55 DMXL1 SNRNP40 WDR90 IFT80 GNB1 GNB2 GNB3 WDR17 BTRC DCAF13 RBBP5 AMBRA1 WDR26 RFWD3 SCAP WDHD1 TLE1 TLE2 GNB5 WDR41 WDSUB1 | 1.72e-17 | 259 | 210 | 26 | PF00400 |
| Domain | WD40 | TBL1Y CORO1C KATNB1 CDC20B WDR55 DMXL1 SNRNP40 WDR90 IFT80 GNB1 GNB2 GNB3 WDR17 BTRC DCAF13 RBBP5 AMBRA1 WDR26 RFWD3 SCAP WDHD1 TLE1 TLE2 GNB5 WDR41 WDSUB1 | 4.02e-17 | 268 | 210 | 26 | SM00320 |
| Domain | WD40_repeat | TBL1Y CORO1C KATNB1 CDC20B WDR55 DMXL1 SNRNP40 WDR90 IFT80 GNB1 GNB2 GNB3 WDR17 BTRC DCAF13 RBBP5 AMBRA1 WDR26 RFWD3 SCAP WDHD1 TLE1 TLE2 GNB5 WDR41 WDSUB1 | 5.79e-17 | 272 | 210 | 26 | IPR001680 |
| Domain | WD_REPEATS_1 | TBL1Y CORO1C KATNB1 CDC20B WDR55 DMXL1 SNRNP40 WDR90 IFT80 GNB1 GNB2 GNB3 WDR17 BTRC DCAF13 RBBP5 AMBRA1 WDR26 RFWD3 SCAP WDHD1 TLE1 TLE2 GNB5 WDR41 WDSUB1 | 9.91e-17 | 278 | 210 | 26 | PS00678 |
| Domain | WD_REPEATS_2 | TBL1Y CORO1C KATNB1 CDC20B WDR55 DMXL1 SNRNP40 WDR90 IFT80 GNB1 GNB2 GNB3 WDR17 BTRC DCAF13 RBBP5 AMBRA1 WDR26 RFWD3 SCAP WDHD1 TLE1 TLE2 GNB5 WDR41 WDSUB1 | 1.08e-16 | 279 | 210 | 26 | PS50082 |
| Domain | WD_REPEATS_REGION | TBL1Y CORO1C KATNB1 CDC20B WDR55 DMXL1 SNRNP40 WDR90 IFT80 GNB1 GNB2 GNB3 WDR17 BTRC DCAF13 RBBP5 AMBRA1 WDR26 RFWD3 SCAP WDHD1 TLE1 TLE2 GNB5 WDR41 WDSUB1 | 1.08e-16 | 279 | 210 | 26 | PS50294 |
| Domain | WD40_repeat_CS | TBL1Y CORO1C KATNB1 CDC20B WDR55 SNRNP40 WDR90 GNB1 GNB2 GNB3 WDR17 BTRC DCAF13 AMBRA1 SCAP WDHD1 TLE1 TLE2 GNB5 WDR41 WDSUB1 | 1.75e-16 | 164 | 210 | 21 | IPR019775 |
| Domain | WD40_repeat_dom | TBL1Y CORO1C KATNB1 CDC20B WDR55 DMXL1 SNRNP40 WDR90 IFT80 GNB1 GNB2 GNB3 WDR17 BTRC DCAF13 RBBP5 AMBRA1 WDR26 RFWD3 SCAP WDHD1 TLE1 TLE2 GNB5 WDR41 WDSUB1 | 4.98e-16 | 297 | 210 | 26 | IPR017986 |
| Domain | - | TBL1Y CORO1C KATNB1 CDC20B WDR55 DMXL1 SNRNP40 WDR90 IFT80 GNB1 GNB2 GNB3 WDR17 BTRC DCAF13 RBBP5 AMBRA1 WDR26 RFWD3 SCAP WDHD1 TLE1 TLE2 GNB5 WDR41 WDSUB1 | 7.82e-15 | 333 | 210 | 26 | 2.130.10.10 |
| Domain | WD40/YVTN_repeat-like_dom | TBL1Y CORO1C KATNB1 CDC20B WDR55 DMXL1 SNRNP40 WDR90 IFT80 GNB1 GNB2 GNB3 WDR17 BTRC DCAF13 RBBP5 AMBRA1 WDR26 RFWD3 SCAP WDHD1 TLE1 TLE2 GNB5 WDR41 WDSUB1 | 9.01e-15 | 335 | 210 | 26 | IPR015943 |
| Domain | G-protein_beta_WD-40_rep | TBL1Y KATNB1 SNRNP40 GNB1 GNB2 GNB3 WDR17 BTRC GNB5 WDR41 WDSUB1 | 2.88e-09 | 85 | 210 | 11 | IPR020472 |
| Domain | - | 8.32e-09 | 25 | 210 | 7 | 3.10.250.10 | |
| Domain | SR | 8.32e-09 | 25 | 210 | 7 | SM00202 | |
| Domain | SRCR-like_dom | 1.13e-08 | 26 | 210 | 7 | IPR017448 | |
| Domain | SRCR_1 | 1.13e-08 | 26 | 210 | 7 | PS00420 | |
| Domain | SRCR_2 | 1.13e-08 | 26 | 210 | 7 | PS50287 | |
| Domain | SRCR | 1.51e-08 | 27 | 210 | 7 | IPR001190 | |
| Domain | Gprotein_B | 4.12e-08 | 10 | 210 | 5 | IPR001632 | |
| Domain | Guanine_nucleotide-bd_bsu | 7.70e-08 | 5 | 210 | 4 | IPR016346 | |
| Domain | SRCR | 8.87e-08 | 21 | 210 | 6 | PF00530 | |
| Domain | RDM_domain_RFPL | 1.38e-05 | 5 | 210 | 3 | IPR022723 | |
| Domain | RDM | 1.38e-05 | 5 | 210 | 3 | PF11002 | |
| Domain | PRY | 1.04e-04 | 42 | 210 | 5 | PF13765 | |
| Domain | PRY | 1.98e-04 | 48 | 210 | 5 | SM00589 | |
| Domain | PRY | 1.98e-04 | 48 | 210 | 5 | IPR006574 | |
| Domain | SH3_9 | 2.46e-04 | 78 | 210 | 6 | PF14604 | |
| Domain | PH | OBSCN PLEKHS1 ARHGAP22 PREX1 ARAP1 SH2B2 PREX2 SPTBN4 SBF2 PSD4 | 2.76e-04 | 229 | 210 | 10 | PF00169 |
| Domain | Sushi | 2.90e-04 | 52 | 210 | 5 | PF00084 | |
| Domain | C1-set | 3.46e-04 | 54 | 210 | 5 | PF07654 | |
| Domain | CCP | 3.46e-04 | 54 | 210 | 5 | SM00032 | |
| Domain | HDAC4_Gln | 3.75e-04 | 3 | 210 | 2 | PF12203 | |
| Domain | Hist_deacetylase_Gln_rich_N | 3.75e-04 | 3 | 210 | 2 | IPR024643 | |
| Domain | SUSHI | 4.11e-04 | 56 | 210 | 5 | PS50923 | |
| Domain | IGc1 | 4.11e-04 | 56 | 210 | 5 | SM00407 | |
| Domain | SPRY | 4.46e-04 | 87 | 210 | 6 | SM00449 | |
| Domain | Sushi_SCR_CCP_dom | 4.46e-04 | 57 | 210 | 5 | IPR000436 | |
| Domain | Ig_C1-set | 4.84e-04 | 58 | 210 | 5 | IPR003597 | |
| Domain | SPRY | 6.73e-04 | 94 | 210 | 6 | PF00622 | |
| Domain | SPRY_dom | 6.73e-04 | 94 | 210 | 6 | IPR003877 | |
| Domain | B30.2/SPRY | 7.12e-04 | 95 | 210 | 6 | IPR001870 | |
| Domain | B302_SPRY | 7.12e-04 | 95 | 210 | 6 | PS50188 | |
| Domain | NGF | 7.44e-04 | 4 | 210 | 2 | PF00243 | |
| Domain | Nerve_growth_factor-like | 7.44e-04 | 4 | 210 | 2 | IPR020408 | |
| Domain | Nerve_growth_factor_CS | 7.44e-04 | 4 | 210 | 2 | IPR019846 | |
| Domain | NGF_1 | 7.44e-04 | 4 | 210 | 2 | PS00248 | |
| Domain | NGF | 7.44e-04 | 4 | 210 | 2 | SM00140 | |
| Domain | Nerve_growth_factor-rel | 7.44e-04 | 4 | 210 | 2 | PD002052 | |
| Domain | NGF_2 | 7.44e-04 | 4 | 210 | 2 | PS50270 | |
| Domain | Nerve_growth_factor-rel | 7.44e-04 | 4 | 210 | 2 | IPR002072 | |
| Domain | Histone_deAcase_II_euk | 7.44e-04 | 4 | 210 | 2 | IPR017320 | |
| Domain | Butyrophylin | 1.15e-03 | 70 | 210 | 5 | IPR003879 | |
| Domain | Lysyl_oxidase | 1.23e-03 | 5 | 210 | 2 | IPR001695 | |
| Domain | Groucho_enhance | 1.23e-03 | 5 | 210 | 2 | IPR009146 | |
| Domain | LYSYL_OXIDASE | 1.23e-03 | 5 | 210 | 2 | PS00926 | |
| Domain | TLE_N | 1.23e-03 | 5 | 210 | 2 | PF03920 | |
| Domain | Lysyl_oxidase_CS | 1.23e-03 | 5 | 210 | 2 | IPR019828 | |
| Domain | Groucho/TLE_N | 1.23e-03 | 5 | 210 | 2 | IPR005617 | |
| Domain | TIF_beta_prop-like | 1.23e-03 | 5 | 210 | 2 | IPR013979 | |
| Domain | eIF2A | 1.23e-03 | 5 | 210 | 2 | PF08662 | |
| Domain | Lysyl_oxidase | 1.23e-03 | 5 | 210 | 2 | PF01186 | |
| Domain | PH | OBSCN PLEKHS1 ARHGAP22 PREX1 ARAP1 SH2B2 PREX2 SPTBN4 SBF2 PSD4 | 1.24e-03 | 278 | 210 | 10 | SM00233 |
| Domain | PH_DOMAIN | OBSCN PLEKHS1 ARHGAP22 PREX1 ARAP1 SH2B2 PREX2 SPTBN4 SBF2 PSD4 | 1.27e-03 | 279 | 210 | 10 | PS50003 |
| Domain | PH_domain | OBSCN PLEKHS1 ARHGAP22 PREX1 ARAP1 SH2B2 PREX2 SPTBN4 SBF2 PSD4 | 1.31e-03 | 280 | 210 | 10 | IPR001849 |
| Domain | Apc4_WD40_dom | 1.39e-03 | 20 | 210 | 3 | IPR024977 | |
| Domain | ANAPC4_WD40 | 1.39e-03 | 20 | 210 | 3 | PF12894 | |
| Domain | EGF_3 | 1.40e-03 | 235 | 210 | 9 | PS50026 | |
| Domain | - | 1.83e-03 | 6 | 210 | 2 | 3.90.1290.10 | |
| Domain | GAR | 1.83e-03 | 6 | 210 | 2 | PS51460 | |
| Domain | GAS2 | 1.83e-03 | 6 | 210 | 2 | PF02187 | |
| Domain | - | 1.83e-03 | 6 | 210 | 2 | 3.30.920.20 | |
| Domain | GAS_dom | 1.83e-03 | 6 | 210 | 2 | IPR003108 | |
| Domain | GAS2 | 1.83e-03 | 6 | 210 | 2 | SM00243 | |
| Domain | DEP | 1.84e-03 | 22 | 210 | 3 | PF00610 | |
| Domain | DEP | 1.84e-03 | 22 | 210 | 3 | PS50186 | |
| Domain | DEP | 1.84e-03 | 22 | 210 | 3 | SM00049 | |
| Domain | EGF-like_dom | 2.08e-03 | 249 | 210 | 9 | IPR000742 | |
| Domain | DEP_dom | 2.10e-03 | 23 | 210 | 3 | IPR000591 | |
| Domain | CUB | 2.22e-03 | 49 | 210 | 4 | PF00431 | |
| Domain | CUB | 2.39e-03 | 50 | 210 | 4 | SM00042 | |
| Domain | TB | 2.55e-03 | 7 | 210 | 2 | PF00683 | |
| Domain | Plectin | 2.55e-03 | 7 | 210 | 2 | PF00681 | |
| Domain | Plectin_repeat | 2.55e-03 | 7 | 210 | 2 | IPR001101 | |
| Domain | PLEC | 2.55e-03 | 7 | 210 | 2 | SM00250 | |
| Domain | EGF_CA | 2.58e-03 | 122 | 210 | 6 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 2.80e-03 | 124 | 210 | 6 | IPR001881 | |
| Domain | EGF_CA | 2.85e-03 | 86 | 210 | 5 | PF07645 | |
| Domain | CUB | 2.96e-03 | 53 | 210 | 4 | PS01180 | |
| Domain | Quinoprotein_ADH-like_supfam | 2.96e-03 | 53 | 210 | 4 | IPR011047 | |
| Domain | AMP-binding_CS | 3.01e-03 | 26 | 210 | 3 | IPR020845 | |
| Domain | SH3 | 3.14e-03 | 216 | 210 | 8 | PS50002 | |
| Domain | VWA_3 | 3.37e-03 | 8 | 210 | 2 | PF13768 | |
| Domain | - | 3.37e-03 | 8 | 210 | 2 | 3.90.290.10 | |
| Domain | ConA-like_dom | 3.42e-03 | 219 | 210 | 8 | IPR013320 | |
| Domain | SH3_domain | 3.52e-03 | 220 | 210 | 8 | IPR001452 | |
| Domain | LisH | 3.73e-03 | 28 | 210 | 3 | IPR006594 | |
| Domain | LisH | 3.73e-03 | 28 | 210 | 3 | SM00667 | |
| Domain | AMP_BINDING | 3.73e-03 | 28 | 210 | 3 | PS00455 | |
| Domain | LISH | 3.73e-03 | 28 | 210 | 3 | PS50896 | |
| Domain | CUB_dom | 3.85e-03 | 57 | 210 | 4 | IPR000859 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR_GNB_G_ERK_SIGNALING_PATHWAY | 1.06e-05 | 27 | 157 | 5 | M47454 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 1.49e-05 | 72 | 157 | 7 | MM14631 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_VGPCR_TO_GNB_G_PI3K_JNK_SIGNALING_PATHWAY | 1.54e-05 | 29 | 157 | 5 | M47466 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CCR_CXCR_GNB_G_PI3K_RAC_SIGNALING_PATHWAY | 2.16e-05 | 31 | 157 | 5 | M47455 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_VGPCR_TO_GNB_G_ERK_SIGNALING_PATHWAY | 2.16e-05 | 31 | 157 | 5 | M47459 | |
| Pathway | REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION | 2.54e-05 | 32 | 157 | 5 | MM14983 | |
| Pathway | REACTOME_PROSTACYCLIN_SIGNALLING_THROUGH_PROSTACYCLIN_RECEPTOR | 5.04e-05 | 19 | 157 | 4 | M926 | |
| Pathway | REACTOME_PROSTACYCLIN_SIGNALLING_THROUGH_PROSTACYCLIN_RECEPTOR | 5.04e-05 | 19 | 157 | 4 | MM15021 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 5.81e-05 | 61 | 157 | 6 | MM15071 | |
| Pathway | REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_CDC42 | 6.24e-05 | 20 | 157 | 4 | M27853 | |
| Pathway | REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_CDC42 | 6.24e-05 | 20 | 157 | 4 | MM15572 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 6.82e-05 | 39 | 157 | 5 | MM14601 | |
| Pathway | REACTOME_PRESYNAPTIC_FUNCTION_OF_KAINATE_RECEPTORS | 7.64e-05 | 21 | 157 | 4 | M27409 | |
| Pathway | REACTOME_PRESYNAPTIC_FUNCTION_OF_KAINATE_RECEPTORS | 7.64e-05 | 21 | 157 | 4 | MM15159 | |
| Pathway | REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_12 | 9.26e-05 | 22 | 157 | 4 | M841 | |
| Pathway | REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_12 | 9.26e-05 | 22 | 157 | 4 | MM15016 | |
| Pathway | REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION | 9.81e-05 | 42 | 157 | 5 | M791 | |
| Pathway | REACTOME_ADRENALINE_NORADRENALINE_INHIBITS_INSULIN_SECRETION | 1.11e-04 | 23 | 157 | 4 | MM15033 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LPAR_GNB_G_RHO_SIGNALING_PATHWAY | 1.11e-04 | 23 | 157 | 4 | M47549 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 1.23e-04 | 44 | 157 | 5 | M26969 | |
| Pathway | REACTOME_G_PROTEIN_ACTIVATION | 1.32e-04 | 24 | 157 | 4 | MM14794 | |
| Pathway | REACTOME_G_PROTEIN_ACTIVATION | 1.32e-04 | 24 | 157 | 4 | M13115 | |
| Pathway | REACTOME_THROMBOXANE_SIGNALLING_THROUGH_TP_RECEPTOR | 1.32e-04 | 24 | 157 | 4 | MM15088 | |
| Pathway | REACTOME_THROMBOXANE_SIGNALLING_THROUGH_TP_RECEPTOR | 1.32e-04 | 24 | 157 | 4 | M18308 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_VGPCR_TO_GNB_G_PI3K_AKT_SIGNALING_PATHWAY | 1.32e-04 | 24 | 157 | 4 | M47460 | |
| Pathway | REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_1 | 1.56e-04 | 25 | 157 | 4 | M811 | |
| Pathway | REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_1 | 1.56e-04 | 25 | 157 | 4 | MM15056 | |
| Pathway | REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA | 1.56e-04 | 25 | 157 | 4 | M14301 | |
| Pathway | REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA | 1.83e-04 | 26 | 157 | 4 | MM15017 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNB_G_RAC_SIGNALING_PATHWAY | 1.83e-04 | 26 | 157 | 4 | M47561 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNB_G_RAC_SIGNALING_PATHWAY | 1.83e-04 | 26 | 157 | 4 | M47562 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CCR5_GNB_G_PLCB_G_PKC_SIGNALING_PATHWAY | 1.83e-04 | 26 | 157 | 4 | M47557 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR_GNB_G_PI3K_AKT_SIGNALING_PATHWAY | 1.83e-04 | 26 | 157 | 4 | M47456 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 2.02e-04 | 108 | 157 | 7 | M17034 | |
| Pathway | REACTOME_GPER1_SIGNALING | 2.13e-04 | 27 | 157 | 4 | MM15664 | |
| Pathway | REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS | 2.14e-04 | 77 | 157 | 6 | MM15044 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 2.30e-04 | 78 | 157 | 6 | M1921 | |
| Pathway | REACTOME_ADRENALINE_NORADRENALINE_INHIBITS_INSULIN_SECRETION | 2.46e-04 | 28 | 157 | 4 | M10679 | |
| Pathway | REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS | 2.64e-04 | 80 | 157 | 6 | M800 | |
| Pathway | WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY | 3.24e-04 | 30 | 157 | 4 | MM15866 | |
| Pathway | REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING | 3.24e-04 | 30 | 157 | 4 | M18193 | |
| Pathway | REACTOME_ACTIVATION_OF_G_PROTEIN_GATED_POTASSIUM_CHANNELS | 3.24e-04 | 30 | 157 | 4 | MM14542 | |
| Pathway | REACTOME_VASOPRESSIN_REGULATES_RENAL_WATER_HOMEOSTASIS_VIA_AQUAPORINS | 3.69e-04 | 31 | 157 | 4 | MM15094 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNB_G_PLCB_PKC_SIGNALING_PATHWAY | 3.69e-04 | 31 | 157 | 4 | M47554 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CCR2_GNB_G_PI3K_NFKB_SIGNALING_PATHWAY | 3.69e-04 | 31 | 157 | 4 | M47540 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_US28_TO_GNB_G_PI3K_NFKB_SIGNALING_PATHWAY | 3.69e-04 | 31 | 157 | 4 | M47541 | |
| Pathway | REACTOME_THROMBIN_SIGNALLING_THROUGH_PROTEINASE_ACTIVATED_RECEPTORS_PARS | 4.18e-04 | 32 | 157 | 4 | M861 | |
| Pathway | REACTOME_THROMBIN_SIGNALLING_THROUGH_PROTEINASE_ACTIVATED_RECEPTORS_PARS | 4.18e-04 | 32 | 157 | 4 | MM15148 | |
| Pathway | REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING | 4.18e-04 | 32 | 157 | 4 | MM15143 | |
| Pathway | REACTOME_G_PROTEIN_BETA_GAMMA_SIGNALLING | 4.18e-04 | 32 | 157 | 4 | M14309 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GPCR_PI3K_SIGNALING_PATHWAY | 4.18e-04 | 32 | 157 | 4 | M47962 | |
| Pathway | REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS | 4.71e-04 | 33 | 157 | 4 | M10322 | |
| Pathway | REACTOME_G_PROTEIN_BETA_GAMMA_SIGNALLING | 4.71e-04 | 33 | 157 | 4 | MM15027 | |
| Pathway | REACTOME_SIGNAL_AMPLIFICATION | 4.71e-04 | 33 | 157 | 4 | MM15020 | |
| Pathway | REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS | 4.71e-04 | 33 | 157 | 4 | MM15058 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNB_G_RHO_SIGNALING_PATHWAY | 4.71e-04 | 33 | 157 | 4 | M47550 | |
| Pathway | REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS | 4.71e-04 | 33 | 157 | 4 | MM15066 | |
| Pathway | BIOCARTA_NUCLEARRS_PATHWAY | 4.71e-04 | 33 | 157 | 4 | MM1448 | |
| Pathway | REACTOME_SIGNAL_AMPLIFICATION | 4.71e-04 | 33 | 157 | 4 | M9379 | |
| Pathway | BIOCARTA_NUCLEARRS_PATHWAY | 5.29e-04 | 34 | 157 | 4 | M16393 | |
| Pathway | WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING | 5.62e-04 | 92 | 157 | 6 | M39441 | |
| Pathway | WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY | 5.92e-04 | 35 | 157 | 4 | M39488 | |
| Pathway | REACTOME_INWARDLY_RECTIFYING_K_CHANNELS | 5.92e-04 | 35 | 157 | 4 | M1075 | |
| Pathway | REACTOME_INWARDLY_RECTIFYING_K_CHANNELS | 6.61e-04 | 36 | 157 | 4 | MM14544 | |
| Pathway | KEGG_OTHER_GLYCAN_DEGRADATION | 6.82e-04 | 16 | 157 | 3 | M17844 | |
| Pathway | REACTOME_COOPERATION_OF_PDCL_PHLP1_AND_TRIC_CCT_IN_G_PROTEIN_BETA_FOLDING | 8.14e-04 | 38 | 157 | 4 | M27656 | |
| Pathway | REACTOME_CHAPERONIN_MEDIATED_PROTEIN_FOLDING | 8.99e-04 | 39 | 157 | 4 | MM15003 | |
| Pathway | REACTOME_AQUAPORIN_MEDIATED_TRANSPORT | 9.90e-04 | 40 | 157 | 4 | MM15115 | |
| Pathway | WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES | TMPRSS13 ACSL3 SSC5D MRC2 CD163L1 SLC27A1 LOXL4 LOXL3 ECI2 DMBT1 CUBN LGALS3BP | 1.15e-03 | 381 | 157 | 12 | M48063 |
| Pathway | REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX | 1.19e-03 | 42 | 157 | 4 | M27272 | |
| Pathway | REACTOME_VASOPRESSIN_REGULATES_RENAL_WATER_HOMEOSTASIS_VIA_AQUAPORINS | 1.30e-03 | 43 | 157 | 4 | M933 | |
| Pathway | REACTOME_GABA_B_RECEPTOR_ACTIVATION | 1.30e-03 | 43 | 157 | 4 | M954 | |
| Pathway | REACTOME_ADORA2B_MEDIATED_ANTI_INFLAMMATORY_CYTOKINES_PRODUCTION | 1.30e-03 | 43 | 157 | 4 | M29837 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 1.40e-03 | 74 | 157 | 5 | M616 | |
| Pathway | REACTOME_GABA_B_RECEPTOR_ACTIVATION | 1.42e-03 | 44 | 157 | 4 | MM15709 | |
| Pathway | REACTOME_SIGNALING_BY_WNT | 1.43e-03 | 239 | 157 | 9 | MM14756 | |
| Pathway | REACTOME_GPER1_SIGNALING | 1.55e-03 | 45 | 157 | 4 | M45008 | |
| Pathway | REACTOME_CA2_PATHWAY | 1.55e-03 | 45 | 157 | 4 | MM15040 | |
| Pathway | REACTOME_VITAMINS | 1.80e-03 | 6 | 157 | 2 | M27125 | |
| Pathway | REACTOME_VITAMINS | 1.80e-03 | 6 | 157 | 2 | MM14840 | |
| Pathway | REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_FRS2_AND_FRS3 | 1.80e-03 | 6 | 157 | 2 | MM15626 | |
| Pathway | REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS | 1.97e-03 | 48 | 157 | 4 | M10775 | |
| Pathway | REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 1.97e-03 | 48 | 157 | 4 | M611 | |
| Pathway | WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION | 2.02e-03 | 159 | 157 | 7 | M48090 | |
| Pathway | PID_RHODOPSIN_PATHWAY | 2.04e-03 | 23 | 157 | 3 | M204 | |
| Pathway | BIOCARTA_WNT_PATHWAY | 2.04e-03 | 23 | 157 | 3 | MM1527 | |
| Pathway | PID_CONE_PATHWAY | 2.04e-03 | 23 | 157 | 3 | M117 | |
| Pathway | BIOCARTA_WNT_PATHWAY | 2.31e-03 | 24 | 157 | 3 | M16517 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 2.33e-03 | 121 | 157 | 6 | M872 | |
| Pathway | REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION | 2.35e-03 | 257 | 157 | 9 | MM15454 | |
| Pubmed | 2.31e-08 | 6 | 220 | 4 | 16884933 | ||
| Pubmed | 1.07e-07 | 8 | 220 | 4 | 24462769 | ||
| Pubmed | 1.07e-07 | 8 | 220 | 4 | 9789084 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | VWA5B2 TBC1D9B INTS1 OBSCN DGKQ CARD10 ZC3H11A DST WDR90 MMP17 LTBP4 PREX1 ARAP1 ENGASE AMBRA1 SH2B2 SLC1A5 GAS2L1 SCAP SBF2 BCAM ZNF839 DHX34 TOP3A | 1.70e-07 | 1105 | 220 | 24 | 35748872 |
| Pubmed | 1.91e-07 | 9 | 220 | 4 | 10339615 | ||
| Pubmed | Evolutionary forces shape the human RFPL1,2,3 genes toward a role in neocortex development. | 2.50e-07 | 3 | 220 | 3 | 18656177 | |
| Pubmed | Genomic organization of the murine G protein beta subunit genes and related processed pseudogenes. | 2.50e-07 | 3 | 220 | 3 | 11913780 | |
| Pubmed | 3.18e-07 | 10 | 220 | 4 | 9733924 | ||
| Pubmed | Gβ2 Regulates the Multipolar-Bipolar Transition of Newborn Neurons in the Developing Neocortex. | 3.18e-07 | 10 | 220 | 4 | 28334111 | |
| Pubmed | A Non-Canonical Function of Gβ as a Subunit of E3 Ligase in Targeting GRK2 Ubiquitylation. | 4.97e-07 | 11 | 220 | 4 | 25982117 | |
| Pubmed | 4.97e-07 | 11 | 220 | 4 | 10644457 | ||
| Pubmed | Neural tube defects and impaired neural progenitor cell proliferation in Gbeta1-deficient mice. | 7.41e-07 | 12 | 220 | 4 | 20186915 | |
| Pubmed | 7.41e-07 | 12 | 220 | 4 | 8636150 | ||
| Pubmed | Differential sensitivity of P-Rex1 to isoforms of G protein betagamma dimers. | 7.41e-07 | 12 | 220 | 4 | 16301321 | |
| Pubmed | 8.45e-07 | 28 | 220 | 5 | 17041588 | ||
| Pubmed | 8.45e-07 | 28 | 220 | 5 | 8858601 | ||
| Pubmed | RIM-BP3 is a manchette-associated protein essential for spermiogenesis. | 9.94e-07 | 4 | 220 | 3 | 19091768 | |
| Pubmed | 9.94e-07 | 4 | 220 | 3 | 1543505 | ||
| Pubmed | The role of G protein beta subunits in the release of ATP from human erythrocytes. | 9.94e-07 | 4 | 220 | 3 | 12512701 | |
| Pubmed | The cationic region of Rhes mediates its interactions with specific Gbeta subunits. | 9.94e-07 | 4 | 220 | 3 | 19255495 | |
| Pubmed | 2.47e-06 | 5 | 220 | 3 | 10508838 | ||
| Pubmed | Structure and evolution of RIM-BP genes: identification of a novel family member. | 2.47e-06 | 5 | 220 | 3 | 17855024 | |
| Pubmed | 2.47e-06 | 5 | 220 | 3 | 11850190 | ||
| Pubmed | 3.48e-06 | 17 | 220 | 4 | 19376773 | ||
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | GALNT2 CNPY4 INTS1 PRPF6 ITGAV TMEM11 ACSL3 CFD FBN1 GVINP1 MRC2 LOXL4 LOXL3 GNB1 GNB2 ALOX15 IPO5 TAPBPL SLC39A10 LGALS3BP TGM2 TKT TLE1 GAA PCNA | 6.08e-06 | 1451 | 220 | 25 | 30550785 |
| Pubmed | 1.37e-05 | 8 | 220 | 3 | 2328987 | ||
| Pubmed | RFPL4 interacts with oocyte proteins of the ubiquitin-proteasome degradation pathway. | 1.37e-05 | 8 | 220 | 3 | 12525704 | |
| Pubmed | 2.90e-05 | 10 | 220 | 3 | 18203754 | ||
| Pubmed | 2.90e-05 | 10 | 220 | 3 | 16183241 | ||
| Pubmed | 2.90e-05 | 10 | 220 | 3 | 20219210 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 3.15e-05 | 248 | 220 | 9 | 24006456 | |
| Pubmed | 3.75e-05 | 30 | 220 | 4 | 24554482 | ||
| Pubmed | 3.97e-05 | 11 | 220 | 3 | 34932372 | ||
| Pubmed | 3.97e-05 | 11 | 220 | 3 | 23603510 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 23726947 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 21695374 | ||
| Pubmed | Neurotrophin-4/5 is required for the early growth of regenerating axons in peripheral nerves. | 3.98e-05 | 2 | 220 | 2 | 15926911 | |
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 15179018 | ||
| Pubmed | Overnight retention of emotional memories is influenced by BDNF Val66Met but not 5-HTTLPR. | 3.98e-05 | 2 | 220 | 2 | 30321558 | |
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 19814996 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 18596173 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 11401409 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 25229715 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 19403693 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 20020740 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 20575060 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 21793125 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 38827321 | ||
| Pubmed | SLC22A4 and SLC22A5 gene polymorphisms and Crohn's disease in the Chinese Han population. | 3.98e-05 | 2 | 220 | 2 | 19659785 | |
| Pubmed | P-Rex2 regulates Purkinje cell dendrite morphology and motor coordination. | 3.98e-05 | 2 | 220 | 2 | 18334636 | |
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 31392756 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 22325173 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 36367618 | ||
| Pubmed | Genome-Wide Association Study of Peripheral Arterial Disease in a Japanese Population. | 3.98e-05 | 2 | 220 | 2 | 26488411 | |
| Pubmed | The Impact of Physical Exercise on the Circulating Levels of BDNF and NT 4/5: A Review. | 3.98e-05 | 2 | 220 | 2 | 34445512 | |
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 21350004 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 36884028 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 28710285 | ||
| Pubmed | Ischemic brain damage in mice after selectively modifying BDNF or NT4 gene expression. | 3.98e-05 | 2 | 220 | 2 | 10616802 | |
| Pubmed | Contribution of the IBD5 locus to Crohn's disease in the Swedish population. | 3.98e-05 | 2 | 220 | 2 | 17340776 | |
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 32964310 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 24018495 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 16835882 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 9706001 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 16519742 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 31623079 | ||
| Pubmed | BDNF, but not NT-4, is necessary for normal development of Meissner corpuscles. | 3.98e-05 | 2 | 220 | 2 | 15722178 | |
| Pubmed | Evidence for association of OCTN genes and IBD5 with ulcerative colitis. | 3.98e-05 | 2 | 220 | 2 | 16361305 | |
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 33039711 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 16796743 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 18980528 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 23127916 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 31591905 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 16469794 | ||
| Pubmed | Non-canonical substrate recognition by the human WDR26-CTLH E3 ligase regulates prodrug metabolism. | 3.98e-05 | 2 | 220 | 2 | 38759627 | |
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 20525682 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 21910182 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 18274826 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 18849643 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 20694145 | ||
| Pubmed | BDNF but not NT-4 is required for normal flexion reflex plasticity and function. | 3.98e-05 | 2 | 220 | 2 | 11438749 | |
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 21606177 | ||
| Pubmed | Transglutaminase is essential for IgA nephropathy development acting through IgA receptors. | 3.98e-05 | 2 | 220 | 2 | 22451718 | |
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 20175187 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 16333318 | ||
| Pubmed | Characterization of organic cation/carnitine transporter family in human sperm. | 3.98e-05 | 2 | 220 | 2 | 12788076 | |
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 16500639 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 21706137 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 12551930 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 15671298 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 12970359 | ||
| Pubmed | Molecular and functional characterization of organic cation/carnitine transporter family in mice. | 3.98e-05 | 2 | 220 | 2 | 11010964 | |
| Pubmed | Significantly decreased mRNA levels of BDNF and MEK1 genes in treatment-resistant depression. | 3.98e-05 | 2 | 220 | 2 | 24709918 | |
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 30666798 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 19228393 | ||
| Pubmed | Sensory but not motor neuron deficits in mice lacking NT4 and BDNF. | 3.98e-05 | 2 | 220 | 2 | 7746325 | |
| Pubmed | Expression patterns of the organic cation/carnitine transporter family in adult murine brain. | 3.98e-05 | 2 | 220 | 2 | 17576045 | |
| Pubmed | Neurotrophin 4 is required for the survival of a subclass of hair follicle receptors. | 3.98e-05 | 2 | 220 | 2 | 9712673 | |
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 19141711 | ||
| Pubmed | 3.98e-05 | 2 | 220 | 2 | 17387389 | ||
| Interaction | GNG2 interactions | 1.28e-05 | 73 | 215 | 7 | int:GNG2 | |
| Interaction | CCT7 interactions | HDAC4 TBL1Y KATNB1 WDR55 PPM1J LOXL4 GNB1 GNB2 BTRC EGLN3 DCAF13 RFPL1 APOBEC3B RFWD3 LGALS3BP TLE2 GNB5 UBASH3B ZRANB1 | 1.39e-05 | 575 | 215 | 19 | int:CCT7 |
| Interaction | CCT5 interactions | HDAC4 TBL1Y KATNB1 PPM1J SNRNP40 LOXL4 GNB1 GNB2 BTRC EGLN3 DCAF13 RNF8 APOBEC3B RFWD3 LGALS3BP TLE2 GNB5 ZRANB1 | 1.45e-05 | 525 | 215 | 18 | int:CCT5 |
| Interaction | CUL4A interactions | HDAC4 CORO1C DHX38 OBSCN PRPF6 PGAP6 COPS7A GCLC SNRNP40 GNB1 GNB2 GNB3 BTRC RBBP5 AMBRA1 WDR26 LGALS3BP WDHD1 TLE1 TLE2 GNB5 ZRANB1 PCNA MYBPC3 | 1.52e-05 | 854 | 215 | 24 | int:CUL4A |
| Interaction | PFDN1 interactions | HDAC4 KATNB1 SNRNP40 GNB1 GNB2 BTRC EGLN3 RFWD3 SPTBN4 ZRANB1 | 2.33e-05 | 179 | 215 | 10 | int:PFDN1 |
| Interaction | MTOR interactions | GNB1 GNB2 GNB3 PREX1 RAP2A AMBRA1 PREX2 GTF3C1 IGHM GNB5 NUMB MAP2K1 ZRANB1 PCNA | 2.46e-05 | 349 | 215 | 14 | int:MTOR |
| Interaction | CCT2 interactions | TBL1Y KATNB1 PPM1J CFD SNRNP40 LOXL4 WDR90 GNB1 GNB2 BTRC EGLN3 DCAF13 AMBRA1 RFPL1 APOBEC3B RFWD3 LGALS3BP TLE2 GNB5 ZRANB1 | 3.24e-05 | 666 | 215 | 20 | int:CCT2 |
| Interaction | RGS6 interactions | 3.43e-05 | 18 | 215 | 4 | int:RGS6 | |
| Interaction | CCT6A interactions | TBL1Y KATNB1 WDR55 SIRPA SNRNP40 LOXL4 GNB1 GNB2 BTRC EGLN3 RAP2A APOBEC3B RFWD3 LGALS3BP TLE2 GNB5 UBASH3B ZRANB1 | 4.27e-05 | 570 | 215 | 18 | int:CCT6A |
| GeneFamily | WD repeat domain containing | TBL1Y CORO1C KATNB1 CDC20B WDR55 DMXL1 SNRNP40 WDR90 IFT80 GNB1 GNB2 GNB3 WDR17 BTRC DCAF13 RBBP5 AMBRA1 WDR26 RFWD3 SCAP WDHD1 TLE1 TLE2 GNB5 WDR41 WDSUB1 | 2.02e-20 | 262 | 155 | 26 | 362 |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 1.27e-04 | 57 | 155 | 5 | 1179 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 4.08e-04 | 206 | 155 | 8 | 682 | |
| GeneFamily | Histone deacetylases, class IIA | 4.33e-04 | 4 | 155 | 2 | 992 | |
| GeneFamily | Acyl-CoA synthetase family | 1.39e-03 | 26 | 155 | 3 | 40 | |
| GeneFamily | EF-hand domain containing|Plakins | 1.98e-03 | 8 | 155 | 2 | 939 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.76e-08 | 183 | 220 | 10 | 2beb5414958d38a5341870d55229f3b1707e76bf | |
| ToppCell | 10x5'-Liver-Myeloid_Dendritic-DC1|Liver / Manually curated celltypes from each tissue | HDAC9 BCL2L14 HLA-DPA1 PPM1J ADRB3 DST BTN1A1 ALOX15 EGLN3 PREX2 | 3.21e-08 | 186 | 220 | 10 | e823529ffd06352c6bdec102f221fdf27f7c7369 |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | HLA-DPA1 CORO1C SIRPA CFD DST SLC39A10 LGALS3BP ITIH5 UBASH3B GAA | 6.08e-08 | 199 | 220 | 10 | 8e9862907b15809d083216e7d6a0f435015e5d15 |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | CORO1C CYP26A1 OBSCN PLEKHS1 FAT2 GCLC LOXL4 ALOX15 GRIP1 IGFL4 | 6.37e-08 | 200 | 220 | 10 | 8827653738a931e4a4545e0c7d75be12bed40740 |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 6.37e-08 | 200 | 220 | 10 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_11|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.33e-07 | 164 | 220 | 9 | ed888b55d9c685096fd785878fcb264f4fee88d6 | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.31e-07 | 175 | 220 | 9 | a1e0a15c69211d6db2edeb101476f0f6e08b90c8 | |
| ToppCell | PND01-03-samps-Mesenchymal-Pericyte-pericyte_E|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 3.74e-07 | 135 | 220 | 8 | 35928195cf34f055b353562c96f451aef2344d64 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.87e-07 | 186 | 220 | 9 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_CCL3+-Alveolar_macrophage_CCL3+_L.1.0.2.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.43e-07 | 189 | 220 | 9 | a59025e82fabd9d60e2438dee85b2644478cc7c8 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 6.82e-07 | 199 | 220 | 9 | c2c42ecf20d1924edc2f899c01dfa5fcf3c210b9 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.82e-07 | 199 | 220 | 9 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 7.11e-07 | 200 | 220 | 9 | 64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts|Control_saline / Treatment groups by lineage, cell group, cell type | 7.11e-07 | 200 | 220 | 9 | a1fc74c1b27e104895910bc7cdce7ba33d30df7e | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_11|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.56e-06 | 163 | 220 | 8 | a09449a502627aa369db600dba5bda93de7ce5c0 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_DC-DC-DC1|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.04e-06 | 169 | 220 | 8 | 488ba50631a64cb9e0d69219491c66ac824c9e7d | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-CD141+_DCs|normal_Pleural_Fluid / Location, Cell class and cell subclass | 2.77e-06 | 176 | 220 | 8 | 195393b38f1335f2cb96125616d75c164a6026c2 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Nptxr-Excitatory_Neuron.Slc17a7.Nptxr-Calb1_(Superficial_layer_pyramidal_cells--Layer_2/3)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.13e-06 | 126 | 220 | 7 | 7dcc79bf35482e8e5e5a1de7279ba080edb70522 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-CD141+_DCs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 3.14e-06 | 179 | 220 | 8 | 99894067e2c2a3ed53abdc5434410c3172693496 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_11|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.84e-06 | 184 | 220 | 8 | 667846c422cfa27e949a24844a305df859cb6760 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_mature-endo_arterial_(9)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.84e-06 | 184 | 220 | 8 | a809b0fa52df8a159f60f87eefcef61220af5e34 | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-GRIA2+_arterial_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.51e-06 | 188 | 220 | 8 | 366a2d59b9c81d8a7659749f9c07efa46b49a39a | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.06e-06 | 191 | 220 | 8 | 5c4e4e9de14edfae072a2a2882220a31bebf51b2 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.06e-06 | 191 | 220 | 8 | 0fae1c2ef9f83ac7721d0a9d69455bf97eed9257 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.06e-06 | 191 | 220 | 8 | 36467322096bc766cd777dae3bfb4e65511e492c | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 5.06e-06 | 191 | 220 | 8 | 3379d145d34f89150f7b06d1340022cfc6b4a6ce | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.06e-06 | 191 | 220 | 8 | 94795daf05061baa3b72a1b01c9e940af86de044 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.26e-06 | 192 | 220 | 8 | beac6b3c191b11add8e39e8d04562b478ea8929e | |
| ToppCell | 368C-Endothelial_cells-Endothelial-B_(Artery)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.26e-06 | 192 | 220 | 8 | aedddccacf60e884af044cefba6c64ca10ac97d2 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-B_(Artery)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.26e-06 | 192 | 220 | 8 | 389d5e6d0689371bfe1d0b06e92e0e6e5573567b | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-ILC3|lymph-node_spleen / Manually curated celltypes from each tissue | 5.26e-06 | 192 | 220 | 8 | e16035b3328f9b1b2e28d234c62ba88387540550 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.47e-06 | 193 | 220 | 8 | 50c2832de75b6469f649355c6b9a75e910d32db3 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.47e-06 | 193 | 220 | 8 | 222829c30ebe47f0ed1e035897e3cd4be10b2a11 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.68e-06 | 194 | 220 | 8 | 663e7e7fe48157e808b4f1a0ea6ad41944e857a2 | |
| ToppCell | 390C-Myeloid-Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 5.90e-06 | 195 | 220 | 8 | ba494be431916d43c1d480f65bed674c0722c710 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.12e-06 | 196 | 220 | 8 | 97e26622d9582b092c18ff5b7e957818f99d9631 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.12e-06 | 196 | 220 | 8 | db64ab27374f82553ee577aec056141170f3656f | |
| ToppCell | PBMC-Control-cDC_3|Control / Compartment, Disease Groups and Clusters | 6.12e-06 | 196 | 220 | 8 | 09d197b321ff9f13c0672ea059c850845b0dbbd5 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.12e-06 | 196 | 220 | 8 | 617103f4a09e009fe96c28eb5e40505a4fd6dcf4 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.12e-06 | 196 | 220 | 8 | f429f045ba45e24717963315832150b12a115bfa | |
| ToppCell | Biopsy_IPF-Epithelial-AT1|Biopsy_IPF / Sample group, Lineage and Cell type | 6.59e-06 | 198 | 220 | 8 | 75bdecbe111fededf6082b11de18b84ca308ef6d | |
| ToppCell | LPS_only-Hematopoietic_Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages|LPS_only / Treatment groups by lineage, cell group, cell type | 6.59e-06 | 198 | 220 | 8 | 2985c80e656e483866c696fa08c38af90311cd66 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Basal_1|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 6.59e-06 | 198 | 220 | 8 | f632342e1e8911dd82b5df171776a84c7dc3f931 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.59e-06 | 198 | 220 | 8 | 4fbf2d56ecf3b116f8ca09dceba8cb93173fd66f | |
| ToppCell | LPS_only-Hematopoietic_Myeloid-Monocytes,_Macrophages|LPS_only / Treatment groups by lineage, cell group, cell type | 6.59e-06 | 198 | 220 | 8 | 5d48539999d7a17f4165f612bf68be26c085e501 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.84e-06 | 199 | 220 | 8 | a60880d6b73b2f33b33790873b8c1e8096863908 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.84e-06 | 199 | 220 | 8 | 9672230aa0bc6a7289050c955f5154ca183a5159 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.84e-06 | 199 | 220 | 8 | e18abe678da293bd01fae55e2f9ab6fdd643d02d | |
| ToppCell | Control_saline-Hematopoietic_Myeloid-Dendritic_cells-pDC|Control_saline / Treatment groups by lineage, cell group, cell type | 6.84e-06 | 199 | 220 | 8 | 34b95e27581bb127e0b921e9c068dc094cb86b37 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.10e-06 | 200 | 220 | 8 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | LPS_anti-TNF-Hematopoietic_Myeloid-Dendritic_cells-pDC|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.10e-06 | 200 | 220 | 8 | 6a34e07e6d77fe3fdd9ff44c4b1e46a023f6d6a2 | |
| ToppCell | COVID-19-COVID-19_Severe-Others-RBC|COVID-19_Severe / Disease, condition lineage and cell class | 7.10e-06 | 200 | 220 | 8 | 308f74e7e13ecc6d133c219c42cc8895a96644c8 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.10e-06 | 200 | 220 | 8 | 6f7f015b5fa1f52374f2c7d9ba339012395eda5f | |
| ToppCell | wk_20-22-Mesenchymal-Fibroblast-intermediate_fibro|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 7.10e-06 | 200 | 220 | 8 | d769723f8fcb37d9b86589e0c41c1d7f16393cfe | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 7.10e-06 | 200 | 220 | 8 | 44a68bacdb3d5bf563bd35952176995850933a81 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.10e-06 | 200 | 220 | 8 | 3a164e3971bcd62b148b813171c103adb81f972e | |
| ToppCell | (3)_ILC|World / shred on Cell_type and subtype | 7.10e-06 | 200 | 220 | 8 | 03554b3f323785b1e0b48fa32de0d92065dd798e | |
| ToppCell | Sepsis-Leuk-UTI-Myeloid-cDC1|Leuk-UTI / Disease, condition lineage and cell class | 7.10e-06 | 200 | 220 | 8 | 186852d54eced4c036876cc891773605068b56b5 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 7.10e-06 | 200 | 220 | 8 | dc61016c61729f69649cfb21f6264e685ce83dea | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.10e-06 | 200 | 220 | 8 | 4f624c3c57d1a84baa86d0830cb1b83ae110bf67 | |
| ToppCell | (30)_ILC|World / shred on Cell_type and subtype | 8.20e-06 | 204 | 220 | 8 | bd9fbd278c05e396463704d711b60d47699e3c09 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_Invariant-Inducer-like-ILC3|bone_marrow / Manually curated celltypes from each tissue | 9.46e-06 | 149 | 220 | 7 | d7f1069f70f3cad6d3700ee2041ed1d4cb7c49ab | |
| ToppCell | COVID-19_Severe-MAIT|COVID-19_Severe / disease group, cell group and cell class | 9.89e-06 | 150 | 220 | 7 | 923ea7ecc0aa05fb0396082cd9c3d1594135f1e0 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Myeloid-microglial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-05 | 157 | 220 | 7 | c762b03e254c73222094725ca8ac1c8eb428bccb | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Myeloid|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-05 | 157 | 220 | 7 | 7fdc0094dd5729990a91a30c1982a14c74650b52 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Myeloid-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-05 | 157 | 220 | 7 | 6b5b08bb5520fcf6f4c0560f7ed7645ec179806d | |
| ToppCell | 343B-Epithelial_cells-Epithelial-H_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.57e-05 | 161 | 220 | 7 | da9eecf919866a9c579d7a707a996cf335213134 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-H_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.57e-05 | 161 | 220 | 7 | d431625c32f59a6b552191f3adc5198bd16ad5cf | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.76e-05 | 164 | 220 | 7 | d167c7a987b9b35d1e7725c803df4f9cd5380e47 | |
| ToppCell | severe-Lymphocytic-B_cells_2|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.76e-05 | 164 | 220 | 7 | a1031e9f945a15186ee14c12be47aa11c3c6583b | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_11|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.91e-05 | 166 | 220 | 7 | b1bebcbe17386cb102b11d551e62d46156ce0c68 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-CD141+_DCs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.91e-05 | 166 | 220 | 7 | 9f14e3ef19d5903278c040be1c477501237173fa | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_11|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.98e-05 | 167 | 220 | 7 | e44743b20a7435c579d8e999ddc4ca119d6753f2 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.14e-05 | 169 | 220 | 7 | 8bca402e144819cb9a8d431d6bf9429be2fff6d6 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.14e-05 | 169 | 220 | 7 | 335619507857383c3b0b507cdf05d786ed59e585 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-05 | 169 | 220 | 7 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.22e-05 | 170 | 220 | 7 | 0cc20322cb3e3e7bbd4daad8785c99f80e355c16 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.22e-05 | 170 | 220 | 7 | 2d880223d01bde4bf777bd6f50b7d2768489075f | |
| ToppCell | 10x5'-Lung-Myeloid_Dendritic-DC1|Lung / Manually curated celltypes from each tissue | 2.40e-05 | 172 | 220 | 7 | 243b8bb01cbec5c1bf8802cbf8a6153356b4c384 | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal-Colon_normal_tissue|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.40e-05 | 172 | 220 | 7 | 94842346c84542a5243bd765e49f4af8bc5182db | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal-Colon_normal_tissue-Colon_normal_tissue|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.40e-05 | 172 | 220 | 7 | 5d654dd030ed22a701e15c5f09002951d99a52e8 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.68e-05 | 175 | 220 | 7 | 1d8aab491dcc27ea5dbfb6462d18ee280b21a05e | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.68e-05 | 175 | 220 | 7 | 427a7ee92fe16a90625946492062d37aa0f7235b | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-ILCP|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.78e-05 | 176 | 220 | 7 | 238244294d08975df6bfa26b2b437db3654408ae | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.88e-05 | 177 | 220 | 7 | 9e65b39fd797b6ce204b6480415810d1923acee5 | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Dendritic-DC1|lymph-node_spleen / Manually curated celltypes from each tissue | 3.21e-05 | 180 | 220 | 7 | a7db1f00566c9acab8b239cbf2e053fb3f2f6a0d | |
| ToppCell | 390C-Myeloid-Dendritic-cDC1|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.32e-05 | 181 | 220 | 7 | d1c69171600b2d2aec96fa86fa757b588c265f7c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.32e-05 | 181 | 220 | 7 | 0c52dd82e6b3dce3d6bb5c13501bf8383f7121e4 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.44e-05 | 182 | 220 | 7 | 84f4322ec3d12cb217009f9215af01ebfabc82b4 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.56e-05 | 183 | 220 | 7 | 06a68fa2be36448064f4668be24a5b85ad85c6e8 | |
| ToppCell | 3'_v3-Lung-Myeloid_Dendritic-DC1|Lung / Manually curated celltypes from each tissue | 3.56e-05 | 183 | 220 | 7 | e4cbd39575b5a4612d9934532e3bad63286f8aa5 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-05 | 184 | 220 | 7 | 6b0c110d8930df99043c3b99cf4d873985126960 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like|lymph-node_spleen / Manually curated celltypes from each tissue | 3.69e-05 | 184 | 220 | 7 | d97471a4fe17cba6880ccf1a04cc00c741558124 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-05 | 184 | 220 | 7 | 35928fc5f7bbf8c7b09181a2bd27e22dff42ec16 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-ILC3|lymph-node_spleen / Manually curated celltypes from each tissue | 3.69e-05 | 184 | 220 | 7 | 479e60f76c191253e23699c9dd7ef7efc08c59ad | |
| ToppCell | COPD-Myeloid-Macrophage_Alveolar|World / Disease state, Lineage and Cell class | 3.69e-05 | 184 | 220 | 7 | 7fd0b227c3750ffb80e41e92c60fcce46656be14 | |
| ToppCell | 3'_v3-GI_small-bowel-Myeloid_Dendritic-DC1|GI_small-bowel / Manually curated celltypes from each tissue | 3.69e-05 | 184 | 220 | 7 | 8e393eea7240584a3cef718bee094e2705ec1891 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_11|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.69e-05 | 184 | 220 | 7 | a6f8b42982ec0cf44b950a2cd9715d068eec4ecb | |
| ToppCell | droplet-Kidney-nan-21m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-05 | 184 | 220 | 7 | 3bffadb0cb2e0d825bdb6cfc5d23f5436cbc3efd | |
| ToppCell | droplet-Kidney-nan-21m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.82e-05 | 185 | 220 | 7 | 33cc0e9d8b54cb7408b51235f2a70e044ebae04d | |
| Drug | gly-asp | 2.85e-06 | 43 | 213 | 6 | CID000097363 | |
| Drug | Dithioerythritol | 3.21e-06 | 4 | 213 | 3 | ctd:D004226 | |
| Disease | aspartate aminotransferase measurement | IL32 TBC1D9B GALNT2 HLA-DPA1 OBSCN WDR55 BDNF LOXL4 IFT80 CNTN2 MTARC1 CNTFR RBBP5 PELI2 CUBN ABCB11 WDR41 UBASH3B MYBPC3 | 3.17e-05 | 904 | 212 | 19 | EFO_0004736 |
| Disease | Barrett Epithelium | 1.91e-04 | 16 | 212 | 3 | C1258085 | |
| Disease | Barrett Esophagus | 1.91e-04 | 16 | 212 | 3 | C0004763 | |
| Disease | glomerulonephritis (biomarker_via_orthology) | 3.81e-04 | 20 | 212 | 3 | DOID:2921 (biomarker_via_orthology) | |
| Disease | hereditary sensory neuropathy (implicated_via_orthology) | 5.07e-04 | 5 | 212 | 2 | DOID:0050548 (implicated_via_orthology) | |
| Disease | bombesin receptor-activated protein C6orf89 measurement | 5.07e-04 | 5 | 212 | 2 | EFO_0801428 | |
| Disease | response to reverse transcriptase inhibitor, HIV-1 infection, peripheral neuropathy | 6.18e-04 | 54 | 212 | 4 | EFO_0000180, EFO_0003100, GO_0061479 | |
| Disease | 3-hydroxybutyrate measurement | 7.48e-04 | 25 | 212 | 3 | EFO_0010982 | |
| Disease | cyclic AMP-dependent transcription factor ATF-6 alpha measurement | 7.56e-04 | 6 | 212 | 2 | EFO_0801505 | |
| Disease | Coxsackievirus Infections | 7.56e-04 | 6 | 212 | 2 | C0010246 | |
| Disease | Myocarditis | 7.56e-04 | 6 | 212 | 2 | C0027059 | |
| Disease | Carditis | 7.56e-04 | 6 | 212 | 2 | C0869523 | |
| Disease | glucose intolerance (biomarker_via_orthology) | 7.56e-04 | 6 | 212 | 2 | DOID:10603 (biomarker_via_orthology) | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 7.77e-04 | 150 | 212 | 6 | EFO_0004611, EFO_0020947 | |
| Disease | cholesterol to total lipids in IDL percentage | 9.22e-04 | 60 | 212 | 4 | EFO_0022233 | |
| Disease | attention deficit hyperactivity disorder (biomarker_via_orthology) | 1.05e-03 | 7 | 212 | 2 | DOID:1094 (biomarker_via_orthology) | |
| Disease | mean platelet volume | HDAC9 GALNT2 CORO1C DAO SIRPA SLFN14 SVEP1 ACSL3 GNB2 ARAP1 MICAL1 RBBP5 SLC22A4 SLC22A5 UBASH3B MAP2K1 MYBPC3 | 1.18e-03 | 1020 | 212 | 17 | EFO_0004584 |
| Disease | diastolic blood pressure, systolic blood pressure | HDAC9 HDAC4 HLA-DPA1 ZC3H11B FBN1 MRC2 LOXL4 BTRC ALOX15 GPC6 TRIM56 GUCY2D WDR41 | 1.19e-03 | 670 | 212 | 13 | EFO_0006335, EFO_0006336 |
| Disease | platelet component distribution width | HDAC9 SCN11A GALNT2 SIRPA SLFN14 SVEP1 ACSL3 RAPGEF3 PREX1 CUBN SEC14L3 NUMB ZNF333 GAA | 1.20e-03 | 755 | 212 | 14 | EFO_0007984 |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 1.27e-03 | 291 | 212 | 8 | EFO_0008317, EFO_0020946 | |
| Disease | Mood Disorders | 1.39e-03 | 168 | 212 | 6 | C0525045 | |
| Disease | acetylcarnitine measurement | 1.40e-03 | 8 | 212 | 2 | EFO_0021038 | |
| Disease | butyrylcarnitine measurement | 1.40e-03 | 8 | 212 | 2 | EFO_0020010 | |
| Disease | FEV/FEC ratio | HDAC9 HDAC4 ZNF184 ZC3H11B ITGAV FBN1 DST MRC2 TRPM8 DMBT1 LTBP4 CNTN2 ARAP1 RBBP5 IL17RC SEC14L3 SBF2 WDR41 UBASH3B | 1.46e-03 | 1228 | 212 | 19 | EFO_0004713 |
| Disease | free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 1.64e-03 | 303 | 212 | 8 | EFO_0004612, EFO_0020945 | |
| Disease | cystic fibrosis (implicated_via_orthology) | 1.79e-03 | 9 | 212 | 2 | DOID:1485 (implicated_via_orthology) | |
| Disease | nervonoylcarnitine (C24:1) measurement | 1.79e-03 | 9 | 212 | 2 | EFO_0800549 | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 1.85e-03 | 121 | 212 | 5 | EFO_0008595, EFO_0020943 | |
| Disease | primary dental caries | 1.86e-03 | 34 | 212 | 3 | EFO_0600095 | |
| Disease | maturity-onset diabetes of the young (implicated_via_orthology) | 2.23e-03 | 10 | 212 | 2 | DOID:0050524 (implicated_via_orthology) | |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 2.28e-03 | 127 | 212 | 5 | EFO_0008595, EFO_0020947 | |
| Disease | hepatitis B (is_implicated_in) | 2.37e-03 | 37 | 212 | 3 | DOID:2043 (is_implicated_in) | |
| Disease | Esophageal Neoplasms | 2.44e-03 | 78 | 212 | 4 | C0014859 | |
| Disease | Malignant neoplasm of esophagus | 2.44e-03 | 78 | 212 | 4 | C0546837 | |
| Disease | Mental Depression | 2.51e-03 | 254 | 212 | 7 | C0011570 | |
| Disease | cataract (implicated_via_orthology) | 2.56e-03 | 38 | 212 | 3 | DOID:83 (implicated_via_orthology) | |
| Disease | refractive error | 2.58e-03 | 326 | 212 | 8 | MONDO_0004892 | |
| Disease | eye measurement, sun exposure measurement | 2.71e-03 | 11 | 212 | 2 | EFO_0004731, EFO_0010729 | |
| Disease | acute insulin response measurement | 2.71e-03 | 11 | 212 | 2 | EFO_0006831 | |
| Disease | lignoceroylcarnitine (C24) measurement | 2.71e-03 | 11 | 212 | 2 | EFO_0800541 | |
| Disease | response to selective serotonin reuptake inhibitor | 2.93e-03 | 82 | 212 | 4 | EFO_0005658 | |
| Disease | ovarian reserve | 3.23e-03 | 12 | 212 | 2 | EFO_0004770 | |
| Disease | tryptophan betaine measurement | 3.23e-03 | 12 | 212 | 2 | EFO_0021017 | |
| Disease | hexanoylcarnitine measurement | 3.23e-03 | 12 | 212 | 2 | EFO_0021040 | |
| Disease | systemic scleroderma | 3.33e-03 | 85 | 212 | 4 | EFO_0000717 | |
| Disease | Profound Mental Retardation | 3.37e-03 | 139 | 212 | 5 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 3.37e-03 | 139 | 212 | 5 | C0025363 | |
| Disease | Mental deficiency | 3.37e-03 | 139 | 212 | 5 | C0917816 | |
| Disease | primary immunodeficiency disease (is_implicated_in) | 3.42e-03 | 42 | 212 | 3 | DOID:612 (is_implicated_in) | |
| Disease | mean arterial pressure | HDAC9 HDAC4 CYP26A1 SVEP1 ZCCHC7 PREX1 ARL3 UTP25 UBASH3B TOP3A | 3.44e-03 | 499 | 212 | 10 | EFO_0006340 |
| Disease | homostachydrine measurement | 3.80e-03 | 13 | 212 | 2 | EFO_0021164 | |
| Disease | dihomo-linolenoylcarnitine (C20:3n3 or 6) measurement | 3.80e-03 | 13 | 212 | 2 | EFO_0800547 | |
| Disease | cerotoylcarnitine (C26) measurement | 3.80e-03 | 13 | 212 | 2 | EFO_0800542 | |
| Disease | cirrhosis of liver | 3.80e-03 | 13 | 212 | 2 | EFO_0001422 | |
| Disease | coffee consumption measurement, tea consumption measurement | 3.90e-03 | 44 | 212 | 3 | EFO_0006781, EFO_0010091 | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 3.96e-03 | 276 | 212 | 7 | EFO_0004612, EFO_0020943 | |
| Disease | triacylglycerol 54:4 measurement | 4.42e-03 | 46 | 212 | 3 | EFO_0010422 | |
| Disease | cleft lip | 4.62e-03 | 284 | 212 | 7 | EFO_0003959 | |
| Disease | red blood cell density measurement | NRN1L ATR ZC3H11B COPS7A GJA5 DST PREX1 CNTN2 SBF2 PALM3 UBASH3B CTRL ZRANB1 PSD4 | 4.77e-03 | 880 | 212 | 14 | EFO_0007978 |
| Disease | bilirubin measurement | 4.89e-03 | 442 | 212 | 9 | EFO_0004570 | |
| Disease | Schizophrenia | HDAC9 HDAC4 DAO CSMD2 BDNF SLC12A5 GCLC GNB3 IPO5 AMBRA1 GRIN2B TGM2 PLA2G4C CTRL | 4.91e-03 | 883 | 212 | 14 | C0036341 |
| Disease | Depressive disorder | 5.07e-03 | 289 | 212 | 7 | C0011581 | |
| Disease | apolipoprotein B to apolipoprotein A1 ratio | 5.28e-03 | 49 | 212 | 3 | EFO_0021897 | |
| Disease | total blood protein measurement | HLA-DPA1 CORO1C CYP26A1 DHX38 ZC3H11B ARAP1 TTC41P SBF2 UBASH3B | 5.41e-03 | 449 | 212 | 9 | EFO_0004536 |
| Disease | carotid artery intima media thickness | 5.48e-03 | 450 | 212 | 9 | EFO_0007117 | |
| Disease | triglycerides to total lipids in medium LDL percentage | 5.59e-03 | 50 | 212 | 3 | EFO_0022334 | |
| Disease | cholesteryl esters to total lipids in IDL percentage | 5.59e-03 | 50 | 212 | 3 | EFO_0022247 | |
| Disease | non-high density lipoprotein cholesterol measurement | MBTD1 GALNT2 CYP26A1 DGKQ ZC3H11B NR1I2 CD163L1 IFT80 MTARC1 ZNF329 ABCB11 UBASH3B | 5.69e-03 | 713 | 212 | 12 | EFO_0005689 |
| Disease | triglyceride measurement, alcohol drinking | 5.73e-03 | 99 | 212 | 4 | EFO_0004329, EFO_0004530 | |
| Disease | Ischemic stroke, plasminogen activator inhibitor 1 measurement | 5.77e-03 | 16 | 212 | 2 | EFO_0004792, HP_0002140 | |
| Disease | idiopathic scoliosis (implicated_via_orthology) | 5.77e-03 | 16 | 212 | 2 | DOID:0060250 (implicated_via_orthology) | |
| Disease | coronary artery disease (is_implicated_in) | 5.94e-03 | 100 | 212 | 4 | DOID:3393 (is_implicated_in) | |
| Disease | phospholipids:total lipids ratio | 6.14e-03 | 227 | 212 | 6 | EFO_0020946 | |
| Disease | triglyceride measurement, alcohol consumption measurement | 6.15e-03 | 101 | 212 | 4 | EFO_0004530, EFO_0007878 | |
| Disease | body fat percentage, type 2 diabetes mellitus | 6.51e-03 | 17 | 212 | 2 | EFO_0007800, MONDO_0005148 | |
| Disease | Hypogammaglobulinemia | 6.51e-03 | 17 | 212 | 2 | C0086438 | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 6.58e-03 | 103 | 212 | 4 | EFO_0008595, EFO_0020944 | |
| Disease | epilepsy (implicated_via_orthology) | 6.59e-03 | 163 | 212 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | Retinitis Pigmentosa | 6.81e-03 | 104 | 212 | 4 | C0035334 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NEALTEGLTCVTTGW | 146 | P40313 | |
| WLVDRSCTVLNVEGD | 461 | Q15758 | |
| EQARLVWVECGSSRG | 1011 | Q9BWT7 | |
| EQGRGSLQDACWTLA | 771 | Q5SNV9 | |
| SEEFLSRVGIWGCLQ | 1981 | Q96N23 | |
| CLQETWTGKEITDGE | 196 | Q8N129 | |
| GELSVCDSISEWVTA | 136 | P23560 | |
| EGSVVWNSAVLRCEA | 736 | Q7Z408 | |
| DLSAIARTLQEWCVG | 166 | Q9UBW8 | |
| AGLVDVAIWVGTCSD | 206 | Q96CG8 | |
| SWGCAGEVRAFLQEN | 286 | Q9UH17 | |
| EVEVGDRTDWAIGVC | 361 | Q13410 | |
| LTRDGLDLWGVVSCD | 491 | Q4VNC1 | |
| DIGWFDSCDIGELNT | 151 | Q2M3G0 | |
| GLIASNQTWCVIDRG | 451 | Q7Z2Y8 | |
| SGSSDNTIRLWDIEC | 481 | Q9Y297 | |
| RVWQIQSCSALTGEG | 151 | P36405 | |
| TWLCNGELVTEGVAE | 151 | P20036 | |
| CDNAIIIWNVGTGEA | 151 | Q9ULV4 | |
| SSDVLAGVRCEWCGV | 206 | P52824 | |
| EIGWFDCNSVGELNT | 186 | O95342 | |
| RGLGNCSANESWTEV | 56 | Q9BZR8 | |
| WEQILGDRIESSACV | 806 | Q4L235 | |
| ESIGIQHWIICDGAS | 2076 | Q96M86 | |
| GATGCELWTSVDVLC | 106 | P13945 | |
| IASGCLDGEVRIWDL | 111 | Q9C0C7 | |
| SDVVWLDGVSCSGNE | 321 | Q9NR16 | |
| NEARDIWINSISCTG | 426 | Q9NR16 | |
| NDDECWSVLEGFRVT | 6 | Q9H257 | |
| LEGAGQQVCWASTEL | 416 | Q569K6 | |
| TGGSCWVLEQTIHLD | 1086 | Q9Y485 | |
| TVLSGACDGEVRIWN | 81 | Q9NV06 | |
| DQITWIGGNEEGCEA | 76 | Q9H6Z9 | |
| AEEVDFAGWLCSTIG | 366 | Q02750 | |
| VSSSEGRALAEEWGC | 126 | P10114 | |
| RGELAVCDAVSGWVT | 91 | P34130 | |
| VCTGDEAANSALLWD | 716 | Q6PCD5 | |
| AGSQAQELAEAWEGC | 1271 | A6NNM3 | |
| AGSQAQELAEAWEGC | 1271 | A6NJZ7 | |
| LTASGDGTCALWDVE | 211 | O14775 | |
| DGTCALWDVESGQLL | 216 | O14775 | |
| ILSSTKAGCTGEEQW | 441 | Q4KMZ1 | |
| RGTAVECSEQAGVWA | 216 | Q8N7Y1 | |
| VWEGLRATEDCATGA | 221 | A6NDB9 | |
| AREGADVIVNCTGVW | 171 | P14920 | |
| CGGVLVAEQWVLSAA | 51 | P00746 | |
| QRACGLLTAEGEEWQ | 121 | O15528 | |
| QRAGEWGTICDDDFT | 61 | P58215 | |
| WLDNVRCVGTESSLD | 96 | Q96JB6 | |
| CGGVGVDSDTIWNEV | 751 | P56524 | |
| GNCASEEVIWEVLNA | 241 | Q9UBF1 | |
| IEGRDCGEATAQWIT | 156 | Q5VT66 | |
| GTVCDNLWDLTDASV | 46 | Q08380 | |
| GTCWGDISENVRVEV | 166 | Q05BQ5 | |
| LSLCVGSQEEAQSWG | 11 | Q86UX2 | |
| EHLSGCIQQWGDSVL | 1781 | Q8N201 | |
| IIGGAESWNCLNTVE | 516 | Q9Y6Y0 | |
| WEGNLAVVSEHCTRG | 611 | Q02846 | |
| ENGSSVLVCLEEGWD | 1401 | Q86WG5 | |
| TGQLSDRCDWIDQAI | 4721 | Q03001 | |
| LEISFRVWQCGGSLE | 336 | Q10471 | |
| EGEALQCLTERAIGW | 1261 | Q9BY66 | |
| LATGGDDCRVNLWSI | 36 | Q9BVA0 | |
| VTTDWDLQKGTGCTE | 386 | Q16549 | |
| DLINEACWDISSSGV | 21 | P12004 | |
| DSESGWITTLQELDC | 2851 | Q9NYQ8 | |
| EACVVSGWGLVSHNE | 136 | Q9H2R5 | |
| GREQLTCTQEGWDFQ | 776 | P07202 | |
| ICDWDSGEVQLLQGE | 421 | Q92817 | |
| SDIDCRWGVISASVD | 291 | P48506 | |
| WEVQDQGTGRFDVCD | 731 | Q6ZMV9 | |
| QTWCREITEIGLQGA | 496 | P16050 | |
| ESSGGWQNRDCSIAL | 341 | Q9UBG0 | |
| GSAGTQEELLRWCQE | 506 | Q8TDZ2 | |
| SGDTTCALWDIETGQ | 161 | P62879 | |
| SGDTTCALWDIETGQ | 161 | P16520 | |
| WLLQVSRESGAACTD | 81 | Q9HCN3 | |
| VFNAETGTWECGRLS | 291 | O75469 | |
| RQVQTSGGLWTECIA | 1066 | O00410 | |
| GRVCVSVEWGSFSDD | 266 | P52790 | |
| TDNIVSQWDVLSGDC | 86 | Q15291 | |
| DEVQETWDDSGCQVG | 1286 | Q7Z442 | |
| RNEEATEGDTATLWC | 3721 | Q5VST9 | |
| EVSRAGATGVQWCLQ | 4181 | Q5VST9 | |
| TDQVCVLEWGAEGVA | 306 | Q86WN1 | |
| CEDIVNTAAWGGQLE | 216 | Q8N6M0 | |
| NIDACGGDIEAWSDT | 471 | Q9UP65 | |
| DSGWTGVNCTENINE | 421 | O60494 | |
| NDECGIIEWVNNTAG | 2371 | Q13535 | |
| SCGWTVISHEGSDIE | 11 | Q9ULG6 | |
| AQGLGAWVSACDTED | 26 | P24001 | |
| WNSVNDLILSAGEDC | 196 | Q9P2H3 | |
| SVTAGTSNEEECWNG | 411 | Q9Y625 | |
| PTDDRSCAVITGNWV | 166 | D3W0D1 | |
| VGEESIQCTSEGVWT | 446 | P20023 | |
| GEASICEDDWNSGER | 286 | P01871 | |
| SCQDGRQLEWGLERT | 836 | P13671 | |
| SGDTTCALWDIETGQ | 161 | P62873 | |
| GEHLWLETNVSGDLC | 176 | O75912 | |
| GTCWQTVIDGRCEIN | 851 | P35555 | |
| DNVATFIGWCRVELG | 101 | Q99501 | |
| AELSCWEEGNGRIAL | 131 | P36382 | |
| VEGGQVLKCDWSSTR | 81 | P06756 | |
| DVTLPCGTANWDAAV | 41 | P26992 | |
| GSNSEGVTDLRLWLC | 16 | Q6B9Z1 | |
| TEADIGSNLRWGCAA | 336 | Q02246 | |
| GNTSEELCVRWTQLG | 651 | P10253 | |
| ESDSEQLCTWVGELF | 501 | Q9NTJ4 | |
| DNLGVCWQEVGADLV | 1346 | Q8N2S1 | |
| TCLAVGTSEGEVQLW | 286 | Q86Y33 | |
| GSSLEQWLSCGERGL | 161 | O43174 | |
| LFDWGTTNCTVGDLV | 71 | Q9NWZ3 | |
| LQGRWLSDECTNAVV | 371 | O75521 | |
| CVLGTFITEWNEGGR | 186 | Q8NFI3 | |
| CGGLGVDSDTIWNEL | 731 | Q9UKV0 | |
| SQRIGELEWSLCAVA | 166 | A8MQT2 | |
| CVRSIQADGLVWGSS | 161 | P24534 | |
| WSQALEDLETCGQSG | 891 | Q9Y3R0 | |
| GSWREGDEVTLICSA | 461 | P50895 | |
| SWDTSDANVVCRQLG | 391 | Q9UGM3 | |
| LDTNGDCSRLVADGW | 911 | Q14147 | |
| CVLRWQFSSDGADIG | 301 | Q9UDX4 | |
| SGRLEVWDAIEGVLC | 986 | Q12770 | |
| GQLEQESCLDGWEFS | 106 | Q9H015 | |
| GQLEQESCLDGWEFS | 106 | O76082 | |
| PEDEANIGASAWICG | 396 | Q9ULF5 | |
| AVALCSEWLQDGVSG | 656 | Q8NAC3 | |
| EGNETVTTRLWGLFC | 331 | Q9H2X9 | |
| DQRWVEDTVGLCGTF | 641 | Q6ZRI0 | |
| KEIAATCSGTEWGQS | 406 | P49757 | |
| NWRDVCEGSATVILG | 66 | Q6NXP2 | |
| SQVLSGCPEEAAAVW | 81 | Q496H8 | |
| ATNRGEEATWTCTVL | 706 | Q68CQ4 | |
| VGTSTEWDLGVCRES | 186 | O75677 | |
| RVCVTQLWGGEDEED | 41 | Q8WV44 | |
| ISSVGIDGCWQADSQ | 101 | Q9H871 | |
| CSQGIVIFSRSWAGD | 431 | P0C7P3 | |
| GLLQAERWETTSCAD | 436 | Q9BX59 | |
| SAGWLLLEDGCEVTV | 26 | O76064 | |
| SWALQCLEDRQQTGG | 446 | Q17RQ9 | |
| TARDWLVCGDSQADG | 516 | Q9ULZ9 | |
| AGSQAQELAEAWEGC | 1271 | Q9UFD9 | |
| WIQDAEECDRAGSVA | 506 | O94906 | |
| SSRAWCSEQDVIVSG | 306 | Q7RTZ1 | |
| EESQPGVWREISVCG | 201 | Q9HAT8 | |
| RTDEAETWDVCLSGL | 471 | O75603 | |
| VDEALTWESGCVGSD | 366 | Q8NDX1 | |
| GTDGLWDVTTDCEVA | 426 | Q5JR12 | |
| HIEGWEGSNLTDICT | 256 | Q8TCU6 | |
| LVCTGSDDGTVKLWD | 166 | Q96DI7 | |
| GEVCTATGERWELQL | 161 | Q9BVL4 | |
| ASCAWSGVAGEEELQ | 21 | P78324 | |
| WAESEGTVACLGAED | 211 | Q92968 | |
| ILCSGSDDGTVRIWD | 581 | Q8IZU2 | |
| TFCSLLGRDEDSWGL | 181 | Q6PJ21 | |
| WLDDVGCVGTEASLS | 531 | A1L4H1 | |
| LSEITCEADGQWSSG | 3041 | Q4LDE5 | |
| WVEAVRCQSLGVFSG | 146 | P0CW24 | |
| CAVGWGSEEVTRDSQ | 366 | Q7Z5H3 | |
| ARIGGTVDTDWCISF | 1186 | Q66K14 | |
| FEDENGQRWLCTGDI | 551 | O95573 | |
| GLVWATECQGLSDTR | 31 | Q96P48 | |
| ECEGLLQQWREEGLS | 56 | Q9UNK9 | |
| VSTEILCRAAWGQEG | 96 | Q9BXL8 | |
| SQDAGCSWSEVRDLT | 131 | Q9UQ49 | |
| GDWTATVVDQQDCTL | 86 | P21980 | |
| EQGSGIDWCLSPADV | 286 | Q5SXH7 | |
| LTEATGRICVSQWEG | 336 | Q5SXH7 | |
| PGESCWQVGLAVEDS | 6 | O95398 | |
| CWAFEGDRGQVTIQL | 251 | Q8TC36 | |
| CIDISNDGTKLWTGG | 621 | Q04724 | |
| EVIQGSGVLDCWADF | 176 | P47901 | |
| ATCSEDGSVRVWALA | 1451 | Q96KV7 | |
| EGTCWLGAELITTNN | 146 | Q9H900 | |
| CGGTLIDAQWVLTAA | 351 | Q9BYE2 | |
| RGILQGDCADWETQL | 76 | Q13360 | |
| RIGDETARWITVGNC | 66 | P17152 | |
| DIWDRESCGGQAAID | 36 | Q8WZ59 | |
| CLLGDGELSEGSVWE | 151 | P29401 | |
| IAVTGDHECLGRWNT | 281 | O95210 | |
| ERLALVDAGTGECWT | 91 | Q6PCB7 | |
| VDAGTGECWTFAQLD | 96 | Q6PCB7 | |
| VTQIVSAEAWGRADC | 116 | P01850 | |
| SFIVTCGSDGDVRIW | 26 | O75717 | |
| IGNETVCTLWQEGRC | 31 | O75152 | |
| SGEGLDSWVADALCL | 596 | Q6P2S7 | |
| GEIRQCWAELESTTQ | 1386 | Q9H254 | |
| CAGRLEVTWGTVCDA | 241 | Q4G0T1 | |
| SCEGRVEFQVQGSWA | 336 | Q4G0T1 | |
| QCVTAVDGEWLAELG | 1131 | Q92620 | |
| IEGWEGSNITDTCTE | 231 | Q70Z35 | |
| SWVADIQGCVDPGDS | 296 | O14492 | |
| DVGTSTEWDLGVCRE | 246 | O75678 | |
| VGTSTEWDLGVCRES | 186 | O75679 | |
| DSTVRLWDVEQGVCT | 431 | Q9BQ87 | |
| WTDCDREGENIGFEI | 146 | Q13472 | |
| LGNETVCTLWQEGRC | 31 | A0A1B0GTU1 | |
| IVTVTDAEGRACGWA | 796 | A8K0R7 | |
| QWTTDRGVLSDTCAE | 261 | Q96JL9 | |
| CFGVGSLQEEGLAWE | 181 | Q8N398 | |
| QWAVEEGACPRTATA | 391 | Q4KMQ1 | |
| SVSGGLQSAVRECKW | 81 | P04628 | |
| LATGDDTGGICLWDQ | 141 | Q9H6Y2 | |
| GCENSVTEGEDGINW | 196 | Q8N3Z6 | |
| LSECSTIDLQDGFGW | 991 | Q9UI33 | |
| VTQIVSAEAWGRADC | 116 | A0A5B9 | |
| TVALSGEECWETLIG | 716 | Q6UXY8 | |
| CSCEELGETGIWQLT | 611 | Q8TF42 | |
| DGNLLDSWEGVRVQC | 476 | Q9H7D7 | |
| CLASGAADGTVVLWN | 111 | Q8N9V3 | |
| WGGSNCLELAVEATD | 651 | Q7Z2W7 | |
| ECQEGEILATGSTAW | 46 | Q6PF06 | |
| ARVGSELCAGWEEQF | 1181 | Q12789 | |
| SVLEGGEAWLECSLR | 511 | P0DP72 | |
| TGGLDNTVRCWDLRE | 606 | Q04725 | |
| LSSLGDGWDCENQEG | 31 | Q86UD4 | |
| QLISCSEDGSVRIWE | 336 | Q9HAD4 | |
| CQRGVTEQLDGSTWD | 686 | Q14202 | |
| GDCLLDSVLQATWGI | 441 | Q9UGI0 | |
| GTCADWETRLENSVS | 96 | Q99676 | |
| SDWQQNSVVICDGLG | 651 | Q9BRZ2 | |
| QSGVAVIDCSWARLD | 116 | Q9UJK0 | |
| SVGDRVSIICWASEG | 36 | A0A075B6H8 | |
| CDTWSLGITAIELGD | 211 | Q8NEV4 | |
| EGCSEWVAALQGLTE | 911 | Q14896 | |
| LTNVEWEDRSGGNFC | 1201 | Q13224 |